The content of this website has been created based on the following scientific articles.

Benign Prostatic Hyperplasia
1. Urology Vol 61, Issue 2, February 2003, Pages 267-273
Benign prostatic hyperplasia: a progressive disease of aging men, Mark Emberton, Gerald L.Andriole, Jean de la Rosette, Bob Djavan, Klaus Hoefner, Remigio Vela Navarrete, Jorgen Nordling, Claus Roehrborn, Claude shulman, Pierre Teillac, Andrea Tubaro and J.Curtis Nickel

Medications
2. Eur Urol 2002 Jul;42(1):1-6
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes. PLESS Study Group.
Roehrborn CG, McConnell JD, Saltzman B, Bergner D, Gray T, Narayan P, Cook TJ, Johnson-Levonas AO, Quezada WA, Waldstreicher J; Proscar Long-term Efficacy and Safety Study.
3. Eur Urol 1998 Sep;34(3):169-75
Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.
Debruyne FM, Jardin A, Colloi D, Resel L, Witjes WP, Delauche-Cavallier MC, McCarthy C, Geffriaud-Ricouard C.
4. BJU International
Volume 91 Issue 3 Page 291 - February 2003
The National Institutes of Health (NIH)-sponsored MTOPS study
Michael G. Wyllie, PhD

Transurethral Needle Ablation Therapy
5. Infections in Urology 1998 vol 11#4-5:148-154, The TUNA Procedure for BPH: Basic Procedure and Clinical Results: Issa MM, Myrick SE, Symbas NP
6. Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, Oesterling JE, A prospective randomized 1-year clinical trial comparing Transurethral Needle Ablation to Transurethral Resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: J. Urol. 1998, 159:1588-1593
7. Roehrborn CG, Issa MM, Brueskewitz R, Naslund MJ, Oesterling JE, Perez-Marrero R, Shumaker BP, Narayan P, Transurethral Needle Ablation for benign prostatic hyperplasia: 12 month results of a prospective, multicenter U.S. study: Urology 1998, 51:415-421
8. Chatelain C, Denis L, Foo KT, Khoury S, McConnell J (Editors), Benign Prostatic Hyperplasia, 5th International Consultation on BPH June 25-28, 2000 Paris, Health Publication Ltd 2001, ISBN 1 898452 45 8, Committee10 - Interventional Therapy for Benign Prostatic Hyperplasia: 397-421
9. Naslund MJ, Benson RC, Cohen ES, Guttierrez-Aceves J, Isa MM, Transurethral Needle ablation TUNA for BPH in Patients with medium lobe enlargement of a prospective multi-center study: J. Urol. 2000; 163(4):A1198 Issa MM, Oesterling JE; Transurethral needle ablation (TUNA): an overview of radiofrequency thermal therapy for the treatment of benign prostatic hyperplasia; Current Opinion in Urology 1996, 6:20-27

Minimally Invasive Therapies
10. Journal of Clinical Laser Medicine & Surgery, 1998 16:29-32 Minimally invasive therapies for the treatment of
symptomatic benign prostatic hyperplasia: The university of Florida experience; Narayan P, Starling J;
11. Curr Opin Urol 2003 Jan;13(1):51-7 Are stents still a useful therapy for benign prostatic hyperplasia? Ogiste JS, Cooper K, Kaplan SA.
12. J Urol. 2002 Oct;168(4 Pt 1):1661
Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data. Kaplan SA
13. Curr Opin Urol. 2002 Jan;12(1):7-14. Review. Minimally invasive therapies for benign prostatic hyperplasia in the new millennium: long-term data.
Zlotta AR, Djavan B.
14. Br J Urol 1998 Feb;81(2):259-64

Transurethral resection of the prostatevs. high-energy thermo therapy of the prostate in patients with benign prostatic hyperplasia: long-term results.
D'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, De La Rosette JJ.
15. Scand J Urol Nephrol 1998 May;32(3):204-10
A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermo therapy for treatment of benign prostatic hyperplasia: two-year follow-up.
Walden M, Acosta S, Carlsson P, Pettersson S, Dahlstrand C.

16. Eur Urol 2000 Jun;37(6):687-94
Long-term outcome of transrectal high- intensity focused ultrasound therapy for benign prostatic hyperplasia.
Madersbacher S, Schatzl G, Djavan B, Stulnig T, Marberger M
17. Eur Urol 2000 Sep;38(3):265-71
Randomised prospective trial of contact laser prostatectomy (CLAP) versus visual laser coagulation of the prostate (VLAP) for the treatment of benign prostatic hyperplasia. 2-year follow-up.
Bryan NP, Hastie KJ, Chapple CR.
18. Urology 2002 Feb;59(2 Suppl 1):12-6
Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy.
Larson TR.

Transurethral Resection of the Prostate (Surgery)
19. Seagroatt V.
Mortality after prostatectomy: selection and surgical approach.
Lancet. 1995 Dec 9;346(8989):1521-4.
20. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF.
Problems of comorbidity in mortality after prostatectomy.
JAMA. 1992 Feb 26;267(8):1077-82.
21. Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, Cohen MM, Ramsey E.
Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
N Engl J Med. 1989 Apr 27;320(17):1120-4.
22. Jenkins BJ, Sharma P, Badenoch DF, Fowler CG, Blandy JP.
Ethics, logistics and a trial of transurethral versus open prostatectomy.
Br J Urol. 1992 Apr;69(4):372-4.
23. Int J Urol 2000 Oct;7(10):373-7
Comparative study of transurethral laser prostatectomy versus transurethral electroresection for benign prostatic hyperplasia.
Wada S, Yoshimura R, Kyo M, Hase T, Masuda C, Watanabe Y, Ikemoto S, Kawashima H, Kishimoto T.
24. BJU Int 2000 Jan;85(1):74-8
Comment in: BJU Int. 2000 Nov;86(7):911.
A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up.
Keoghane SR, Lawrence KC, Gray AM, Doll HA, Hancock AM, Turner K, Sullivan ME, Dyar O, Cranston D.
25. Curr Opin Urol 2002 Jan;12(1):19-23
Transurethral resection of the prostate: the new old standard.
Littlejohn JO Jr, Ghafar MA, Kang YM, Kaplan SA.
26. Urology 2002 Aug;60(2):305-8
Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia.
Shingleton WB, Farabaugh P, May W.